Dera Bassi

Jump to

Nectar Life gets Brazil approval for API facility; stock up

The company has received ANVISA cGMP approval for Brazil for its Cephalosporin API‘s manufacturing facility in Dera Bassi, Punjab.
Nectar Life soars 15% on European cGMP nod for Punjab unit

Investors lapped up more shares of Nectar Lifesciences on Tuesday after the hearlthcare firm has received approval from European cGMP for Cephalosporin APIs' manufacturing facility in Dera Bassi, Punjab. The stock rallied 15 percent intraday. cGMP is current good manufacturing practices.
Nectar Lifesciences receives USFDA nod for Dera Bassi plant

Nectar Lifesciences today said it has received approval from the US health regulator for its manufacturing facility at Dera Bassi in Punjab.
Nectar Lifesciences manufacturing unit gets US FDA nod

Nectar Lifesciences has received US Food and Drugs Administration (FDA) approval for its Active Pharmaceutical Ingredients (API) manufacturing plant Unit-II in Dera Bassi, Punjab.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Dera Bassi

Nectar Life gets Brazil approval for API facility; stock up

Nectar Life soars 15% on European cGMP nod for Punjab unit

Nectar Lifesciences receives USFDA nod for Dera Bassi plant

Nectar Lifesciences manufacturing unit gets US FDA nod